RCT in 281 patients with sepsis (276 analysed): biomarker-guided anakinra or interferon gamma vs placebo achieved a SOFA decrease of at least 1.4 by day 9 in 35.1% vs 17.9%; 28-day mortality did not differ. More anaemia with anakinra, haemorrhage with interferon gamma.
RCTn = 281 patients
Giamarellos-Bourboulis et al. Precision Immunotherapy to Improve Sepsis Outcomes: The ImmunoSep Randomized Clinical Trial